IR

Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases

Financial Information

80,000 60,000 40,000 20,000 0 -20,000
80,000 60,000 40,000 20,000 0 -20,000

202049,400

202158,256

2022 46,946

Total assets

80,000 60,000 40,000 20,000 0 -20,000

2020 2,104

2021 19,496

2022 20,637

Total liabilities

80,000 60,000 40,000 20,000 0 -20,000

2020 47,296

2021 38,761

2022 26,309

Total capitals

80,000 60,000 40,000 20,000 0 -20,000

2020 -4,126

2021 -13,071

2022 -3,935

Operating profit

  • 2020
  • 2021
  • 2022

Balance sheet (unit : 1 million won)Scroll left and right to read.

Item 2020 2021 2022
Current Assets 12,975 20,808 19,241
Non-Current Assets 36,425 37,448 27,706
Total Assets 49,400 58,256 46,946
Current Liabilities 1,044 1,846 18,283
Non-Current Liabilities 1,060 17,649 2,354
Total Liabilities 2,104 19,496 20,637
Capital 4,849 4,866 4,866
Retained Earnings -6,507 -19,519 -32,252
Total Equity 47,296 38,761 26,309

Income statement (unit : 1 million won)Scroll left and right to read.

Item 2020 2021 2022
Sales 0 909 0
Operating Profit -5,287 -13,011 -3,995
Profit before Income Tax -4,126 -13,071 -3,935
Net Profit -4,126 -13,071 -3,935